{
  "url": "https://openlegislation.uk/eu-regulation-2013-1017/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2013-1017/annex.json",
  "legislation": "eur/2013/1017",
  "legislation_title": "Commission Regulation (EU) No 1017/2013 of 23 October 2013 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2013-1017",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "Rejected health claims\nApplication – Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\n‘Hypo-caloric snacks (KOT products)’\nContributes to reduce the adipocytes size at the abdominal level, in the context of a low-calorie diet\nQ-2011-00016\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nIsoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP)\nPeptides IPP and VPP help to maintain normal blood pressure\nQ-2011-00121\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nAppl’In® polyphenolic apple extract powder (Malus domestica)\nAppl’In® contributes to decrease glycaemic response in women\nQ-2011-00190\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nCoffee C21\nRegular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body\nQ-2011-00783\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nDiacylglycerol (DAG) oil\nSubstituting your usual vegetable oil with DAG oil helps in the management of body weight through weight loss\nQ-2011-00751\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nSpermidine\nSpermidine prolongs the growing phase (anagen) of the hair cycle\nQ-2011-00896\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nBimuno® (Bimuno® GOS)\nRegular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce intestinal discomfort\nQ-2011-00401\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nSugar beet fibre\nSugar beet fibre decreases intestinal transit time\nQ-2011-00971",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2013/1017/annex",
    "retrieved_at": "2026-11-01T14:48:18.726117+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}